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To define the genetic contributions affecting individual differ-
ences in seizure threshold, a b carboline [methyl-b-carboline-
3-carboxylate (b-CCM)]-induced model of generalized seizures
was genetically dissected in mice. b-CCM is a GABAA receptor
inverse agonist and convulsant. By measuring the latency to
generalized seizures after b-CCM administration to A/J and
C57BL6/J mice and their progeny, we estimated a heritability of
0.28 6 0.10. A genome wide screen in an F2 population of
these parental strains (n 5 273) mapped quantitative trait loci
(QTLs) on proximal chromosome 7 [logarithm of the likelihood
for linkage (LOD) 5 3.71] and distal chromosome 10 (LOD 5
4.29) for seizure susceptibility, explaining ;22 and 25%, re-
spectively, of the genetic variance for this seizure trait. The best
fitting logistic regression model suggests that the A/J allele at
each locus increases the likelihood of seizures approximately
threefold. In a subsequent backcross population (n 5 223), we
mapped QTLs on distal chromosome 4 (LOD 5 2.88) and
confirmed the distal chromosome 10 QTLs (LOD 5 4.36). In the
backcross, the C57BL/6J allele of the chromosome 10 QTL
decreases the risk of seizures approximately twofold. These
QTLs may ultimately lead to the identification of genes influ-
encing individual differences in seizure threshold in mice and
the discovery of novel anticonvulsant agents. The colocaliza-
tion on distal chromosome 10 of a b-CCM susceptibility QTL
and a QTL for open field ambulation and vertical movement
suggests the existence of a single, pleiotropic locus, which we
have named Exq1.
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Wide inter-individual differences (;12-fold) in seizure thresholds
have been documented in humans as measured by the electrical
stimulus dose needed to induce a seizure (Sackeim et al., 1991;
Colenda and McCall, 1996). Despite intense investigations at the
molecular, cellular, neural network, slice, and whole-brain levels
(McNamara, 1992, 1994), the pathophysiology of paroxysmal dis-
charges and seizure threshold regulation are incompletely under-
stood. Genetic factors contribute to a predisposition for seizures
with a complex inheritance (Anderson et al., 1986; Berkovic et al.,
1998). Recent conflicting results in mapping loci for juvenile
myoclonic epilepsy (Greenberg and Delgado-Escueta, 1993; Liu
et al., 1995, 1996; Elmslie et al., 1996; Serratosa et al., 1996) have
highlighted the problems in mapping loci for complex diseases
such as epilepsy. These difficulties include (1) incomplete pen-
etrance, (2) the presence of phenocopies, (3) genetic heterogene-
ity (different loci giving rise to a single phenotype), (4) multigenic
modes of inheritance, (5) gene interactions, and (6) environmen-
tal factors. These complexities render the mapping and positional
cloning of loci for complex behaviors challenging in humans. As
an alternative, we have chosen to focus on a mouse model of
drug-induced epilepsy that offers the advantages of planned mat-
ings and controlled environments. Rodent models have already
demonstrated utility in mapping genes and quantitative trait loci
(QTLs) for epilepsy (Applegate et al., 1989, 1990; Neumann and
Seyfried, 1990; Neumann and Collins, 1991; Rise et al., 1991;
Frankel et al., 1994, 1995a,b; Frankel, 1995; Noebels, 1996; Buck
et al., 1997; Cox et al., 1997; Ferraro et al., 1997; Skradski et al.,
1998).
In the present study, we have genetically dissected the variation
in seizure response to a b carboline convulsant, methyl-b-
carboline-3-carboxylate (b-CCM). b-CCM binds to GABAA re-
ceptors and exerts an effect opposite to benzodiazepines (i.e., acts
as an inverse agonist) to reduce GABA-mediated chloride ion
conductance at low concentrations (Im et al., 1995; Barnard et al.,
1998). The latter reduces postsynaptic GABAergic inhibitory
activity (Tunnicicliff and Raess, 1991; Olsen and Avoli, 1997).
b-CCM is a convulsant when administered to chickens, mice, rats,
rabbits, and baboons (Croucher et al., 1984; Prado de Carvalho et
al., 1984; Chapman et al., 1985, 1987; Massotti et al., 1985).
In mice, convulsant doses of b-CCM induce a single brief (10
sec) convulsion of cortical origin with rapid propagation to the
hippocampus (Prado de Carvalho et al., 1983). We and others
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have previously demonstrated large differences among inbred
mouse strains in their sensitivity to b carboline convulsants with
a significant heritable component (Kosobud and Crabbe, 1990;
Martin et al., 1991, 1992, 1994; Mathis et al., 1995; Chapouthier
et al., 1998). We have focused in particular on the sensitive A/J
and resistant C57BL/6J strains, which differ markedly in their
seizure susceptibility to various chemical convulsants (Kosobud
and Crabbe, 1990). Recently, segments of chromosomes 4, 9, and
13 have been provisionally mapped as affecting b-CCM-induced
seizures (Martin et al., 1995; Clement et al., 1996). Here, we
report the results of a genome-wide search for QTLs influencing
susceptibility to b-CCM in intercross and backcross populations
derived from A/J and C57BL/6J inbred mice.
MATERIALS AND METHODS
Animals. Male and female A/J (A), C57BL/6J (B6), B6AF1, and F2
hybrid mice 7–8 weeks of age were obtained from Jackson Laboratory
(Bar Harbor, ME). B6AF2 mice (F2; n 5 273) were derived from an
intercross of offspring of a cross between B6 females and A males. N2
mice (n 5 220) were produced at the University of Texas Southwestern
Medical Center (UTSW) from a backcross of B6AF1 females and A
males. All mice of the same strain and gender were housed in groups of
four to five animals with food and water ad libitum. Animals were
maintained under a 12 light /dark cycle with lights on at 6 A.M. F2 mice
were identified by ear notching at 7–8 weeks of age followed by 10 d of
adaptation previous to phenotyping. N2 mice were ear-notched at 4
weeks of age and tested at 7–8 weeks of age. Mice were tested individ-
ually and weighed on the day of testing. Before testing for response to
b-CCM, mice were subjected to sequential testing in behavioral para-
digms: exploratory behavior in an open field (O-F) and light–dark (L-D)
transitions, except for the backcross offspring, which were not tested in
the L-D transition test. The results of these studies (exploratory behavior
in an O-F and L-D transitions of the F2 hybrids) were reported elsewhere
(Gershenfeld and Paul, 1997; Gershenfeld et al., 1997). All experiments
followed the NIH Guide for the Care and Use of Laboratory Animals.
Seizure testing. Mice were tested for their vulnerability to seizures
induced by b-CCM (Research Biochemicals, Natick, MA) at 10 weeks of
age in the F2 hybrids and at 7–8 weeks of age in the backcross offspring.
b-CCM was dissolved in 0.1N HCl (100 ml /mg b-CCM) and diluted in
saline to a final concentration of 1 mg/ml. b-CCM (5 mg/kg) was
administered intraperitoneally in a volume of 0.1 ml/20 gm body weight.
The animals received b-CCM at least 10 min after being isolated in
individual cages. Preliminary dose and time–response studies indicated
that 5 mg/kg was the optimal dose and that 10 min was the optimal
observation period for b-CCM-induced seizures. Nonseizing animals
were assigned a value of 600 sec. Thus, mice were observed for the
following dependent variables: (1) seizure susceptibility dichotomized as
either susceptible (seizure occurred) or resistant (absence of a seizure)
and (2) latency of seizures (measured in seconds). Generalized, myo-
clonic seizures were defined as motor behavior consisting of tonic and
clonic alternations, accompanied by a loss of the righting reflex.
DNA preparation and genotyping. DNA was prepared and genotyped as
described previously (Gershenfeld and Paul, 1997). Briefly, DNA was
genotyped by PCR with MapPair primers (Research Genetics, Hunts-
ville, AL). Initially, a panel of 102 approximately equally spaced CA
repeat microsatellite DNA markers were selected (Dietrich et al., 1992,
1996), providing a whole genome screen at a spacing of ;14 cm.
Exploratory behavior in an open field. O-F behavior was performed and
analyzed as described previously (Gershenfeld et al., 1997), except that
the backcross offspring were tested at UTSW for O-F in a newer appa-
ratus (Opto-Varimex-3, Columbus Instruments, Columbus, OH; 730 lux
at cage floor). The dimensions of the square field were 43 3 43 3 30.5
cm, and the vertical sensor was positioned 8 cm above the cage floor.
Briefly, O-F behavior consisted of three consecutive 5 min epochs (e1, e2,
e3) (15 min total), and the following dependent measures were assessed:
(1) initial total distance (TDe1), the distance travelled or ambulated
during the initial 5 min epoch, epoch 1; (2) habituated total distance
(TDe3), the distance travelled or ambulated during the last 5 min epoch,
epoch 3; and (3) vertical movements (VM15), the sum of vertical move-
ments (rearings) during the first trial of 15 min.
Statistical analysis. The presence or absence of seizures was treated as
a dichotomous, nominal variable. Latency to seizure was measured as a
continuous variable. The genetic component of the variance in the F2
generation and its error (i.e., the broad sense heritability) were estimated
as described (Falconer, 1963). Analysis of components of the means was
performed as described previously (Neumann et al., 1993). Because no
suitable transformation of the latency-to-seizure trait variable could be
found (to obtain a normal distribution and equalize the variances among
groups), the data were subsequently analyzed nonparametrically. By rank
ordering the latency-to-seizure variable, the “ceiling effect” of arbitrarily
assigning nonseizing mice a value of 600 sec was mitigated.
Overall differences in latency to seizure and percentage of animals
with a myoclonic seizure were compared across gender, strain, and
generation by nonparametric tests for significant differences with Mann–
Whitney U, Kruskal–Wallis, and x 2 tests (Statview 4.5 and SuperAnova,
Abacus Concepts and JMP 3.02, SAS Institute).
For linkage detection, we initially used x 2 tests of independence
between markers and seizure susceptibility (i.e., the presence or absence
of seizure), which are inherently model-free. For single-point linkage of
seizure latency and a marker, the seizure latency values were rank-
ordered and analyzed by the Kruskal–Wallis test for the F2 population
and the Mann–Whitney U tests for the backcross (N2) population (Sokal
and Rohlf, 1995). The Mapmaker/QTL (Lander et al., 1987; Paterson et
al., 1991; Lincoln and Lander, 1992) and Map Manager QTLb21 (Manly,
1998) programs were used to confirm, localize, and estimate the percent-
age of the phenotypic variance explained for each QTL. For interpreting
the seizure linkage results, we used the empirically derived statistical
threshold criteria generated from permutation tests on the data (shuffling
randomly the genotypes and phenotypes 10,000 times) (Churchill and
Doerge, 1994; Manly, 1998). These empirically derived threshold defi-
nitions for suggestive and significant linkage correspond to the estab-
lished p values based on the number of times that one would be expected
to find such a result at random under the more stringent assumption of
a dense marker map genome scan (Lander and Kruglyak, 1995). Sugges-
tive linkage thresholds define a level at which just one occurrence at
random in a genome scan would be expected, whereas the significant
linkage threshold would be surpassed statistically 0.05 times in a genome
scan. For the F2 population, the permutations of the ranked seizure
latency determined the thresholds for suggestive and significant linkage
as logarithm of the likelihood for linkage (LOD) scores of 2.3 and 3.7,
respectively. For the N2 population, the threshold values for suggestive
and significant linkage were LOD scores of 1.4 and 2.7, respectively.
Finally, the data were modeled by stepwise linear and nominal logistic
regression to find the best fitting model and to obtain odds ratios
(Kleinbaum, 1994; Sokal and Rohlf, 1995). For interpreting the explor-
atory behavioral traits’ linkage results, we used the published guidelines
(Lander and Kruglyak, 1995). The percentage of the genetic component
of the variance explained by a QTL was estimated by dividing the
percentage of the phenotypic variance explained by the estimated heri-
tability. Epistatic interactions were examined by linear regression anal-
ysis, testing for statistical interactions among mapped loci as described
(Cheverud and Routman, 1995).
RESULTS
Segregation analysis
A/J mice were more susceptible to b-CCM-induced myoclonic
seizures than B6 mice in both latency to seizure and proportion
of tested mice that seized ( p , 0.0001) (Table 1). The parental
strains differed in effect size by 1 SD in their latency to b-CCM-
induced seizures. Preliminary experiments with the parental
strains at 7 and 10 weeks (data not shown) showed no difference
in seizure frequency or latency to seizure between age groups.
Seizure resistance showed partial dominance. The F1 hybrids
were less susceptible than the theoretical midparental (m) values
for both seizure frequency and latency but were more susceptible
than B6 mice without reaching statistical significance. The broad
sense heritability of seizure latency was estimated in the F2
hybrids to be 0.28 6 0.10; however, this estimate makes the false
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assumption of a normal distribution of the data. Analysis of the
components of the means was consistent with a simple model of
the mode of inheritance requiring no interaction parameters. The
parameters m (0.45), a (0.23), and d (20.12) were calculated from
the seizure frequencies in the B6, A, and F1 populations. The
predicted seizure frequencies in the F2 (m 1 d/2 5 0.39) and N2
(m 1 a/2 1 d/2 5 0.51) were not significantly different from the
observed values (36 and 51%).
Figure 1. QTL likelihood plots on the F2 population for ( A) chromosome 7 and ( B) chromosome 10 and on the N2(B6AF1xA/J) backcross population
for (C) chromosome 4 and (D) chromosome 10 from Mapmaker/QTL analyses. Logarithm of the likelihood ratio for linkage (LOD) score is plotted
against map distance in centimeters for the traits of seizure latency, rank-ordered (F), average of three trials of light7dark transitions (AvgLD, f), initial
O-F total distance ambulated (TDe1, ), habituated O-F total distance ambulated (TDe3, [tridf]), and O-F vertical movements (VM15, »). For the F2
hybrids with 2 df, the published threshold values for suggestive and significant linkage are LOD 5 2.8 and LOD 5 4.3, respectively, whereas the
empirically derived threshold values from 10,000 permutations for the ranked latency to seizure gave values of 2.3 and 3.7, respectively. For the
N2(B6AF1xA/J) cross with 1 df, the published threshold values for suggestive and significant linkage are LOD 5 1.9 and LOD5 3.3, respectively,
whereas the empirically derived values for the ranked latency to seizure gave values of 1.4 and 2.7. These QTL plots used the genotyping of 11 and 12
DNA markers for chromosome 7 and 10 in the F2 hybrids, whereas the backcross offspring used the genotyping of 7 and 10 DNA markers for
chromosomes 4 and 10, respectively.
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Linkage analysis of seizure susceptibility in
intercross offspring
From the phenotypic rankings of the latency-to-seizure trait, F2
animals within the lowest and highest (17% tails) of the distribu-
tion (“phenotypic extremes”) were selected for initial genotyping.
We mapped loci using a three-stage strategy. In stage I, x2 tests of
independence between markers and seizure susceptibility were
calculated from a genome-wide screen on the phenotypic ex-
tremes. Six peak marker loci (D1Mit353, D7Mit78, D8Mit69,
D10Mit14, D15Mit11, and D18Mit4) were identified with x2 tests
surpassing a relatively low threshold of statistical significance
( p 5 0.05), which was selected to limit type II errors (Elston,
1994). In the second stage, flanking DNA markers surrounding
the six stage I candidate loci were selected and genotyped on the
extremes. Then, we merged this genotype data on the seizure
phenotypic extremes with our previous genotype data on the
behavioral traits’ phenotypic extremes, creating a pooled dataset.
With this enlarged dataset, the Mapmaker/QTL computer pro-
gram was used to localize and model these potential QTLs. Only
two loci located on chromosomes 7 and 10 met the “suggestive”
level of significance criteria for LOD cutoff thresholds for link-
age. In stage III, we “genotyped” the entire F2 population with
markers in the regions of interest. This step reduced errors
attributable to assumptions implicit in modeling the whole distri-
bution from non-normally distributed populations with missing
data. Finally, the F2 data were reanalyzed with the single point
nonparametric statistics (Sokal and Rohlf, 1995), Mapmaker/
QTL, and logistic regression.
D7Mit308 on proximal chromosome 7 displayed association
with seizure susceptibility (x2 5 14.8, p 5 0.006, 2 df; n 5 267)
and seizure latency (Table 2, Fig. 1A).
D10Mit180 on distal chromosome 10 was associated with sei-
zure susceptibility (x2 5 15.77, p 5 0.004, 2 df; n 5 271) and
seizure latency (Table 2, Fig. 1B). The B allele for the potential
QTL near D10Mit180 displayed near complete dominance.
The best-fitting logistic regression model suggests that the A
allele at the D7Mit308 locus increases the likelihood of seizures
;3.3-fold, and the A allele at the D10Mit180-linked locus in-
creases the likelihood of seizure by ;2.7-fold (Table 3). The
contribution of these QTLs to the phenotypic variance was esti-
mated similarly from stepwise linear regression and Mapmaker/
QTL (Table 2), where each locus individually accounted for
5–7% of the phenotypic variation. Together the two loci explain
11–12% of the phenotypic variation and roughly 40% of the
genetic variation in the F2 generation. No epistatic interactions
were detected between these loci. No additional QTLs were
mapped in models that fix the identified QTL or in models that
included only susceptible mice (n 5 98).
Linkage analysis of seizure susceptibility in
backcross offspring
The chromosome 10 QTL was robustly confirmed in the back-
cross offspring. D10Mit237, which is located ;4 cm distal to
D10Mit180, displayed significant association with seizure suscep-
tibility (x2 5 19.30, 1 df, p , 0.0001; n 5 214) and seizure latency
(Table 2, Fig. 1D).
A genome-wide scan with 102 markers in the backcross mapped
only one other QTL at the suggestive level of statistical signifi-
Table 1. Seizure frequency and latency in parental, F1, F2 hybrid, and
backcross mice injected with b-CCM
Generation n % Seizure
Latency to seizure
Mean SD (sec)
C57BL6/J 49 22 510 171.94
A/J 66 68a 248b 251.96
(B6xA)F1 40 33 494 195.67
F2 273 36 419 246.11
(B6AF1xA)N2 220 51 337 260.86
Maximum seizure latency was 600 sec.
aA/J significantly different from B6 and F1 by Fisher’s Exact test, p , 0.0006.
bMann–Whitney U test, p , 0.0001.
Table 2. QTL mapping summary and mean comparisons at mapped loci by genotype
Cross and trait
Mapmaker QTL Mean comparisons by genotype
Marker 1 cM
Pos. in
cM
LOD
score
%
Var Weight df
H,U,
orF
test p value
Mean of
B/B
(% Sz)
Mean of
B/A
(% Sz)
Mean of
A/A
(% Sz)
F2 intercross
b-CCM seizure D7Mit308 1 0 13.7 3.71 6.1 22.03 2 17.3 0.0002 161.4 (18.3) 127.5 (41.4) 116.9 (47.6)
Latency, ranked D10Mit180 1 0 67.8 4.29 7.0 7.0 2 18.9 ,0.0001 152.8 (25.5) 146.1 (29.5) 110.4 (52.9)
N2 backcross
b-CCM seizure D4Mit68 1 4 70.7 2.88 6.8 31.63 1 4281 0.0005 123.3 (41.1) 93.8 (62.9)
Latency, ranked D10Mit237 1 4 76.1 4.36 8.8 154.85 1 4398 0.0003 413.8 (38.9) 257.3 (65.4)
O-F exploration
Sqrt. Tot. Dist.
initial (TDel)
D10Mit237 1 2 74.1 3.19 6.8 4.71 1,208 12.69 0.0005 40.8 36.5
Sqrt. Tot. Dist.
habituated (TDe3)
D10Mit237 1 4 76.1 6.53 12.8 6.87 1,212 27.84 ,0.0001 34.9 28.4
Sqrt. VM15 D10Mit237 1 4 76.1 2.98 6.2 1.27 1,208 18.33 ,0.0001 8.5 7.2
The empirically derived threshold values for “suggestive” and “significant” linkage with the ranked latency to seizure are LOD values of 2.3 and 3.7 for the F2 intercross and
LOD values of 1.4 and 2.7 for the N2 backcross, respectively. For the open–field square root transformed traits in the backcross, we used the statistical criteria proposed by
Lander and Krugylak (1995), namely a p # 5.2 3 1025 (LOD 3.3) for significant linkage and a p # 1.6 3 1023 (LOD 1.9) for suggestive linkage, and F tests were performed
by genotype to compare means in an ANOVA. For the nonparametric analyses comparing the latency-to-seizure means, a Kruskal–Wallis tie-corrected H test was performed
for the F2 comparisons and a Mann–Whitney U test for the N2 backcross. The O-F exploration square root transformed variables were (1) total distance initial (TDe1), the
distance travelled or ambulated during the initial 5 min epoch, epoch 1; (2) total distance habituated (TDe3), the distance travelled or ambulated during the last 5 min epoch,
epoch 3; and (3) vertical movements (VM15), the sum of vertical movements (rearings) during the first trial of 15 min.
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cance. D4Mit68 on distal chromosome 4 was associated with
seizure susceptibility (x2 5 10.3, 1 df, p 5 0.0013; n 5 217) and
seizure latency (Table 2, Fig. 1C).
The best fitting logistic regression model suggests that the B
allele at the D4Mit68-linked locus increased the likelihood of
resistance by 2.3-fold, and the B allele at the D10Mit237-linked
locus increased it by 2.8-fold (Table 4). Each locus accounted for
6–9% of the phenotypic variance (Table 2). Together these two
loci explained ;11.8% of the phenotypic variance. The chromo-
some 7 locus mapping in the F2 hybrids and the previously
mapped loci (Martin et al., 1995; Clement et al., 1996) on chro-
mosomes 9 and 13 could not be confirmed. No statistical epistatic
interactions were detected, and no additional QTLs were mapped
in models that fix the identified QTL.
Linkage analysis of behavioral phenotypes in
backcross offspring
O-F behaviors in the backcross offspring were tested for associa-
tion with marker loci on distal chromosome 10 because the
co-localization of a seizure susceptibility QTL with a previously
reported QTL for O-F exploratory (Gershenfeld et al., 1997) and
fear-like (Gershenfeld and Paul, 1998) behaviors in B6AF2 hy-
brid mice suggested the possibility of a single pleiotropic QTL
(Fig. 1B). D10Mit237 displayed significant association with O-F
initial (TDe1) and habituated (TDe3) ambulation and O-F ver-
tical movement (VM15) in the backcross population (Table 2,
Fig. 1D). Consequently, we named this distal chromosome 10
locus Exq1 (exploratory and excitability QTL) because it appears
to affect both O-F exploratory behavior (TDe1, TDe3, VM15)
and b-CCM-induced seizure susceptibility. Exq1 explains 6–13%
of the phenotypic variance and from 13–31% of the genetic
variance for the various O-F exploratory traits listed in the
backcross population (Table 2). Consistent with the observations
in the F2 population (Gershenfeld et al., 1997), the B6 allele of
Exq1 is an increasing allele for all the O-F traits in the backcross
populations (Table 2).
DISCUSSION
By using the GABAA receptor inverse agonist b-CCM as a
pharmacological probe, we examined the genetic basis of individ-
ual differences in seizure behavior in offspring derived from the
A and B6 mice. In general, the A strain is a seizure-susceptible
strain, and B6 mice are a seizure-resistant strain based on their
susceptibility to nine chemoconvulsants (Kosobud and Crabbe,
1990). We selected this particular drug-induced paradigm as a
model of individual differences in susceptibility to seizures, be-
cause previous work had shown robust strain differences (Martin
et al., 1991, 1993, 1994; Mathis et al., 1994, 1995) that reflect
presumed genetic differences in seizure threshold and “GABA
inhibitory tone”(Tunnicicliff and Raess, 1991; Olsen and Avoli,
1997). The drug has been demonstrated to rapidly induce a single
brief convulsion within 10 min, and the drug has behavioral
activity for at least 30 min after its injection (Prado de Carvalho
et al., 1984). By measuring the latency to seizure after a 5 mg/kg
i.p. injection with b-CCM, we confirmed significant between-
strain differences and estimated a heritability of 0.28 6 0.10 in
this F2 population, similar to our previous findings from RI
strains (Mathis et al., 1995). Genome wide screens mapped QTLs
for seizure susceptibility on proximal chromosome 7 and distal
chromosome 10 in intercross offspring, and on distal chromosome
4 and distal chromosome 10 QTL in backcross offspring. Only the
QTL on chromosome 10 was detected in both the intercross and
the backcross, probably because of dominance relationships. The
confidence interval of the suggestive QTL on distal chromosome
4 overlaps with that of a b-CCM susceptibility QTL, Bis 1 (Martin
et al., 1995). In the crosses reported here, we could not confirm
the provisionally mapped QTLs on chromosomes 9 or proximal
13, inferred as influencing b-CCM-induced seizures (Martin et
al., 1995; Clement et al., 1996).
We have named the chromosome 7 QTL Bis 4 (b-carboline-
induced seizure 4). This QTL confirmed our previous suggestive
locus (near Pmv15) from a recombinant inbred strain linkage
analysis (Mathis et al., 1995), whereas the other potential QTLs
may be small effect loci or spurious loci secondary to limited
statistical power (Neumann, 1992; Belknap et al., 1996). The
broad, flat Bis4 likelihood plot (Fig. 1A) has a large 1 LOD
support interval ranging from 2 to 30 centimorgans (cM) and
corresponds to human regions 19q13, 11p15, and 15q11–q13. This
interval contains several appealing candidate genes: Atp1a3
(Na,K-ATPase 1a3), Atp1b3 (Na,K-ATPase 1b3), Grik5 (gluta-
mate receptor, kainate 5, g 2), and Scn1b (voltage-gated sodium
channel, type I, b polypeptide). We cannot exclude as candidate
genes the cluster of three GABAA receptor subunits (a5, b3,
gamma3) or the seizure susceptibility QTLSzf1 (Frankel et al.,
1994) at roughly 28 cM. Human association studies for juvenile
myoclonic epilepsy in this region have been equivocal (Sander et
al., 1997), but mice deficient in the b3 subunit have an increased
susceptibility to seizures (Homanics et al., 1997). The Bis4 QTL
interval is probably proximal to the Asp3 locus, which influenced
audiogenic seizures (Neumann and Collins, 1991; Banko et al.,
1997). In addition, we believe that Bis4 is probably distinct from
Asp3, because previous work has shown no correlation between
b-CCM-induced seizures and audiogenic seizures among 33
B10.D2 recombinant congenic strains (Martin et al., 1992).
We named the distal chromosome 10 locus Exq1 because it
appears to affect O-F exploratory behavior (TDe1, TDe3,
VM15), L-D behavior, and b-CCM-induced seizure behavior.
Although the most parsimonious explanation for the pleiotropic
effects of distal chromosome 10 is a single locus, much higher
resolution fine mapping will be needed to exclude the possibility
of two closely linked loci. The steep QTL likelihood plots (Fig. 1)
for Exq1 on the habituated total distance (TDe3) in the backcross
suggest a more discrete localization of the locus to the telomeric-
most 15 cM, corresponding to human chromosomes 12q11–14 and
12q24. If one interprets our strain differences as individual dif-
ferences in major behavioral systems [where open field behavior
reflects a behavioral inhibition system (Kagan et al., 1988; Gray
and NcNaughton, 1996; Gershenfeld et al., 1997), where b-CCM-
induced seizures interrogates the “set point” of GABA neuronal
inhibition (Nutt et al., 1992), and where the L-D paradigm re-
flects a “fear-like” system (Gershenfeld and Paul, 1997)], then a
mechanistic understanding of the Exq1 gene product should be
informative in understanding the interrelationship among these
higher order behaviors. We speculate that this locus functions as
a neuronal modulator (distinct from the known neurotransmitter
and receptor complexes) because no known candidate genes map
to this region. Although conceivable neuromodulators abound,
the list might include factors known to affect GABAA receptor
function such as growth factors (Wan et al., 1997), protein kinases
(Lin et al., 1996; McDonald and Moss, 1997), neurosteroids (Paul
and Purdy, 1992; Purdy et al., 1992; Lambert et al., 1996; Rup-
precht et al., 1996), endogenous benzodiazapine ligands (Polc,
1995; Wichlinski, 1996), and transcriptional factors (Berninger et
al., 1995; Sadar et al., 1996; Ashiya and Grabowski, 1997) differ-
Gershenfeld et al. • Mapping QTLs for b-CCM-Induced Seizures J. Neurosci., May 15, 1999, 19(10):3731–3738 3735
entially regulated between the two strains. The ultimate posi-
tional cloning of this locus may clarify the etiological mechanism.
From a therapeutic perspective, one might speculatively consider
the role of a dominantly acting locus as a “protective” allele,
especially in “all or none” threshold behaviors such as seizures. It
is possible that the effect of relatively modest genes on an under-
lying threshold may be clinically significant. As developments in
brain stem cells and vectors progress (Lawrence et al., 1995;
O’Connor et al., 1997; Xiao et al., 1997; Zhang et al., 1997), one
can imagine gene therapy for people with medication refractive
epilepsy, where one might overexpress a mixture of such protec-
tive loci as Exq1 in the susceptible individual’s tissue to increase
the seizure threshold or lessen the spread of paroxysmal neuronal
discharges.
The distal chromosome 4 QTL interval mapped in the back-
cross confirms the previously mapped Bis 1 QTL near je (Martin,
Clement et al., 1995). Two serotonin receptor gene subunits that
map to this region (Htr1da and Htr1db) have some plausibility as
regulators of seizure threshold. A third candidate gene is the
Slc9a1 (formerly known as NheI), which encodes a Na1/H1
exchange protein. The etiology of the slow-wave epilepsy mutant
mouse was recently attributed to a Slc9a1 null mutation (Cox et
al., 1997). The region of conserved synteny in humans corre-
sponds to 1p36–32.
Several limitations should be considered in interpreting our
findings. The sample populations represent crosses between just
two strains of mice and may not be generalizable to other strains.
The sample sizes of the F2 and backcross offspring populations
were relatively small, and hence QTLs with an effect of ,5% of
the phenotypic variance would not reach statistical significance.
In general, the complexity of interpreting drug response patterns
in populations derives from the multiple genetic factors affecting
pharmacokinetics as well as pharmacodynamics. We cannot for-
mally rule out pharmacokinetic explanations because we did not
measure brain b-CCM levels. In this regard, strain differences in
b-CCM-induced seizures between the NIH:GP (an outbred pop-
ulation of Swiss mice) and a derived line NIH:N population were
attributed to a pharmacokinetic difference at 4–6 weeks of age,
whereas no such strain difference in susceptibility was detected at
8–10 weeks of age (Schweri et al., 1983b). Although the plasma
t1/2 of b-CCM in rats is short (;3 min) (Schweri et al., 1983a),
experiments in mice have demonstrated active drug effects in
behavioral paradigms for at least 30 min after injection at sub-
convulsant doses (Prado de Carvalho et al., 1984). However, it
seems unlikely that pharmacokinetic differences could explain
our results because (1) we phenotyped animals at 8–10 weeks of
age, (2) the A and B6 lines differ for many chemoconvulsants
(Kosobud and Crabbe, 1990), and (3) seizures usually occur
within the first 6 min.
The Bis4 and Exq1 QTLs reported here are likely to be distinct
from previously mapped loci for various mouse seizure pheno-
types (Neumann and Seyfried, 1990; Neumann and Collins, 1991,
1992; Rise et al., 1991; Frankel et al., 1994, 1995a,b; Miner and
Marley, 1995; Clement et al., 1996; Buck et al., 1997; Ferraro et
al., 1997; Skradski et al., 1998), and our distal chromosome 4 QTL
supports the chromosomal assignment of Bis1 (Martin et al.,
1995). Previous work on genetic correlations among inbred
strains with chemoconvulsants (Kosobud and Crabbe, 1990) and
the .80 discrete knockout transgenic strains presenting with
seizures as a phenotype (Noebels, 1996) suggest a multiplicity of
genes affecting seizure susceptibility. The current mapping of
distinct loci specific for vulnerability to a GABAA receptor in-
verse agonist model of seizures underscores the emerging con-
struct of multigenic, genetically heterogenous models of epilepsy,
where each mouse model may uniquely represent an underlying
seizure mechanism (Anderson et al., 1986; Frankel et al., 1994;
McNamara, 1992, 1994). We anticipate that the positional cloning
and functional analysis of the loci influencing b-CCM-induced
seizures will substantially contribute to our understanding of the
basic cellular mechanisms affecting seizure vulnerability. More-
over, the positional cloning of the Exq1 locus with its presumed
pleiotropic effects on seizure threshold, open-field, and fear-like
behaviors may provide insights into the pathophysiology of indi-
vidual differences in CNS excitability.
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